What is MAIA's current stock price?

MAIA (MAIA Biotechnology, Inc.) is currently trading at $1.35 with a market cap of $82.1M.

What sector is MAIA Biotechnology, Inc. in?

MAIA Biotechnology, Inc. (MAIA) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

MAIA MAIA Biotechnology, Inc.

AMEXHealthcare

$1.35-2.88%ClosedMarket Cap: $82.1M

As of 2026-08-24 16:00

Why MAIA matters now

MAIA Biotechnology, Inc. (MAIA) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.35 with -2.88% on the session and $82.1M in market capitalization.

The latest indexable market news headline is "Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)" from GlobeNewsWire.

Latest News

Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA)GlobeNewsWire · 2026-08-17

MAIA: High Bar For ECB Surprise, Alphabet CAPEX In Focus: 3 Minutes MLIVBloomberg Markets and Finance · 2026-07-23

MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion TrialGlobeNewsWire · 2026-07-08

MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion TrialGlobe News Wire · 2026-07-08

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung CancerGlobeNewsWire · 2026-06-25

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

AMEX

Beta

0.25

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.